Every category has dozens of candidate molecules, formulations, and manufacturers, generic, biosimilar, and innovative alike, at any given time. The traditional sourcing process relies on individual expertise, relationships, and, frankly, luck to identify which one is genuinely best-in-class versus merely available. VAIS™ replaces luck with a repeatable evaluation discipline.
The system continuously benchmarks candidate drugs against first, second, third, and every subsequent generation of alternative already in the market, comparing therapeutic value, safety data, manufacturing quality signals, and cost structure, so our sourcing team is never working from a partial picture.
A disciplined, four-stage evaluation.
No candidate reaches our sourcing team without clearing all four stages, the same sequence, every category, every market.
See Regulatory Standards
